SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-07-02 22:22
Tx date 2025-06-27 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights 		$11,750
+23,980 vol
$0.49 each 		95,273
Filed 2024-10-08 09:20
Tx date 2024-09-30 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights 		$11,749
+19,583 vol
$0.60 each 		71,293
Filed 2023-06-25 23:23
Tx date 2023-06-20 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights 		$11,750
+18,077 vol
$0.65 each 		51,710
Filed 2022-08-21 07:39
Tx date 2022-08-16 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$10,749
+15,638 vol
$0.69 each 		100,000
Filed 2022-08-21 07:36
Tx date 2022-08-16 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-8,992.98
-14,100 vol
$0.64 each 		0
Filed 2022-08-21 07:33
Tx date 2022-08-16 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-984.32
-1,538 vol
$0.64 each 		0
Filed 2022-05-19 21:57
Tx date 2022-05-18 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+12,113 vol 		19,793
Filed 2022-05-17 12:52
Tx date 2022-05-13 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights
+16,096 vol 		33,633
Filed 2021-12-28 11:44
Tx date 2021-12-22 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights
+17,537 vol 		17,537
Filed 2021-12-28 11:43
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
Filed 2021-08-26 16:33
Tx date 2021-08-16 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-7,418.0568
-6,153 vol
$1.21 each 		58,500
Filed 2021-08-17 08:33
Tx date 2021-08-17 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-6,153 vol 		26,687
Filed 2021-05-28 16:09
Tx date 2021-05-28 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$8,700
+6,000 vol
$1.45 each 		62,181
Filed 2021-05-27 10:56
Tx date 2021-05-26 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,771
+1,181 vol
$1.50 each 		56,181
Filed 2021-05-21 12:10
Tx date 2021-05-20 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+7,680 vol 		7,680
Filed 2021-05-20 14:43
Tx date 2021-05-20 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$16,015
+10,000 vol
$1.60 each 		55,000
Filed 2020-12-23 08:51
Tx date 2020-12-22 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$8,550
+9,500 vol
$0.90 each 		45,000
Filed 2020-12-23 08:50
Tx date 2020-12-22 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$14,355
+16,500 vol
$0.87 each 		35,500
Filed 2020-12-23 08:45
Tx date 2020-12-22 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,740
+9,000 vol
$0.86 each 		19,000
Filed 2020-12-09 12:55
Tx date 2020-12-04 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,848
+7,596 vol
$0.77 each 		84,362